8 May 2019

8th Meet-up TOP500 Innovators: we are part of it

Patrycja Wizińska-Socha, CEO of Nestmedic S.A. is going to take part in a panel discussion during the 8th Meet-up TOP500 Innovators, which will take place between 8 and 10 May in Wrocław. This time, Meet-up TOP500 Innovators has joined forces with another important event: the Polish-American Innovation Bridge.

According to the host of the event, the TOP500 Innovators Association – the largest non-governmental organisation in Poland, bringing together members of the scientific community, technology transfer professionals, innovation and project management experts, start-ups, and representatives of the high technology industry: “Poland is still very far down in the innovation ranking. Being in the bottom 4th is not something that could inspire optimism… On the other hand, an increasing number of Polish start-ups are taking a great risk and try to become players on the global market. As the »Structure of Start-Ups in Poland and their Financing« report says, we currently have about 3000 start-ups, of which 46% cooperate with scientists, 29% have their own laboratory facilities, and every fifth one has been founded by scientists. So how to multiply good practices, exchange knowledge, and be able to develop the teams? And from a more philosophical perspective: How to make the dreams of technology development come true as dynamically growing technology companies?”

Patrycja Wizińska-Socha, CEO of Nestmedic S.A. is one of the guest-speakers, invited to the event to participate in the panel discussion: “MedTech-related start-up technology companies”.

You can find more about the event at: http://top500meetup.pl/

29 Apr 2019

The first Pregnabit devices now on the Finnish market

Nestmedic has received an order for the supply of devices and services to Helsinki University Hospital (HUS) in Finland. This is the result of an agreement concluded in 2018 with a Finnish distributor, Steripolar Oy, as well as a successful pilot implementation of the Pregnabit system at HUS. The order provides for the supply of the teleCTG Pregnabit devices and the licence to use the Pregnabit system.

Photo: Focus archives

“This is a very important project in the implementation of the foreign market expansion strategy for the Pregnabit system. Our solution has been appreciated by a specialist hospital in a very demanding market. This is also the outcome of our successful cooperation with a business partner in Finland, Steripolar Oy. With this project we are starting a new chapter in the development of our company on foreign markets, comments Sławomir Bartoszcze, Director of International Expansion at Nestmedic S.A.

Finland is considered to be one of the most advanced markets in the world as far as the implementation of telemedical solutions is concerned. At the same time, it is a country with a substantial level of expenditure on pregnancy healthcare and perinatal care. The annual birth rate in Finland stands at about 50,000. More than 30% of labours take place at HUS – the hospital that now has the teleCTG Pregnabit system on the list of its medical services.

13 Apr 2019

Pregnabit demonstrated on a scientific conference in Finland

The power of partnership matters. The Pregnabit system has been just demonstrated by our Finnish partner, Steripolar to a wide audience of gynaecologists and obstetricians during a conference organised by the Finnish Society of Perinatology. The event takes place between 11 and 12 April in Helsinki, Finland. Our telemedical solution: Pregnabit teleCTG arouses great interest among practicing doctors and midwives.

Fot. Archiwum Steripolar